Drugmakers criticize new crypto-protection requirements for drug marking in Russia

Leading Russian and foreign drug manufacturers operating in the local market have warned the national government about the forthcoming rise in prices that will come about as a result of certain innovations introduced by the Russian government in the national pharmaceutical industry.

One of such innovations is the use of crypto-protection during marking of drugs in Russia, reports The Pharma Letter’s local correspondent.

To date, representatives of some leading global drugmakers operating in Russia have appealed to the national government and Parliament with a request to reject the introduction of crypto-protection in the domestic pharmaceutical industry. According to them, this threatens the domestic pharmaceutical industry with isolation, and could also lead to a significant increase in drug prices due to additional costs for producers.